Outset Medical to Present at the 20th Annual Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

Outset Medical, Inc. (Nasdaq: OM) announced participation in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference on September 13, 2022, at 11:55am PT / 2:55pm ET. The event will be accessible through a live and archived webcast on the company’s website. Outset Medical is known for its innovative Tablo Hemodialysis System, designed to simplify dialysis for providers and enhance patient experiences. This technology enables dialysis delivery in various settings with integrated water purification and data analytics capabilities.

SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 20^th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2022 at 11:55am PT / 2:55pm ET.

A live and archived webcast of the fireside chat will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220830005061/en/

Jim Mazzola

Vice President, Investor Relations

jmazzola@outsetmedical.com

Brian Johnston

Gilmartin Group

(332) 895-3222

investors@outsetmedical.com

Source: Outset Medical, Inc.

FAQ

When is Outset Medical participating in the Morgan Stanley Global Healthcare Conference?

Outset Medical is participating in the Morgan Stanley Global Healthcare Conference on September 13, 2022, at 11:55am PT / 2:55pm ET.

Where can I watch the Outset Medical fireside chat?

The fireside chat can be viewed live and archived on the Outset Medical website in the 'Investors' section.

What is the significance of the Tablo Hemodialysis System?

The Tablo Hemodialysis System is a groundbreaking technology that reduces the complexity and cost of dialysis, allowing for flexible care anywhere.

What are the capabilities of the Tablo system?

Tablo integrates water purification and on-demand dialysate production, enabling it to function as a mobile dialysis clinic with advanced data analytics.

What company trades under the ticker OM?

Outset Medical, Inc. trades under the ticker OM on Nasdaq.